Donald Buzinkai, vice president, controller and chief accounting officer at Ann Arbor-based Kaydon Corp., will leave the company Oct. 15 to become CFO of New York-based Kroll Inc., after just over one year at Kaydon.
Kaydon (NYSE: KDN), a designer-manufacturer of bearings and other engineered products for industrial, aerospace, medical device and electronic equipment makers, announced in a disclosure to the U.S. Securities and Exchange Commission that Buzinkai's last day would be Friday.
Buzinkai, 40, joined Kaydon in June 2009 after nearly two years as vice president, controller and principal accounting officer of Alpharma Inc., a specialty pharmaceuticals maker acquired by Tennessee-based King Pharmaceuticals Inc. in late 2008.
Buzinkai said Tuesday his departure was motivated in part by an opportunity to work again with Jeff Campbell, the former Alpharma CFO who became CFO earlier this year at Falls Church, Va.-based Altegrity Inc.
Altegrity acquired Kroll in August for $1.13 billion.
"Kaydon is a good, well-run company, and I benefited from my time here," he said. "This was a good opportunity to connect again with a former mentor."
Kroll is a risk consulting firm that provides legal services, forensic audits, business intelligence, due diligence and fraud investigation services.
Under the terms of his separation agreement with Kaydon, Buzinkai must repay a portion of his initial relocation expenses and signing bonus totaling $117,213 by Thursday.
Product Model | Inside Diameter | Outside Diameter | Thickness |
28NQ4017 KOYO | 40 | 17 | |
RNA49/22R KOYO | 39 | 17 |